Using absolute prostate-specific antigen (PSA) thresholds to make decisions about diagnostic testing and biopsies remains controversial (Journal Watch Top Story Dec 31 2004), but PSA velocity (the ...
Elevated serum prostate-specific antigen (PSA) levels can indicate the presence of prostate cancer, although PSA levels are also elevated in some nonmalignant conditions, which affects the reliability ...
We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...
We need better ways to determine which prostate-specific antigen (PSA)-detected localized prostate cancers are most likely to progress. The rate at which the PSA level rises (i.e., PSA velocity) prior ...
Serum PSA values >4.0 ng/ml are routinely used to select patients for prostate biopsy, although this approach misses some early-stage cancers. Some researchers advocate dropping the PSA threshold to 2 ...
Arnhem, November 2009 – The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity ...
A phase IIb trial of docetaxel concurrent with radiotherapy plus hormotherapy versus radio hormonotherapy in high-risk localized prostate cancer (QRT SOGUG trial): Preliminary report for design, ...
Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be ...
CHICAGO (Reuters) - A sudden spike in blood levels of prostate specific antigen, or PSA, is not an accurate way to predict prostate cancer, and testing for such changes can lead to overtreatment, U.S.
PSA blood test Compared with absolute PSA, PSA velocity associated more with increased likelihood of progression among men on active surveillance for prostate cancer. PSA velocity (PSAV) is associated ...
One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today. Listen 0:00 Jim, a 57-year-old Boston ...
To the Editor: There are some basic methodologic flaws in the work by D'Amico et al. (July 8 issue). 1 In their multivariate analyses, the prostate-specific antigen (PSA) velocity was modeled as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results